Integra LifeSciences Holdings Corp buy Wells Fargo & Company
Start price
05.12.23
/
50%
€37.80
Target price
05.12.24
€45.24
Performance (%)
-35.45%
Price
14.05.24
€24.40
Summary
This prediction is currently active. Massive losses of -35.45% have been the result for the BUY prediction by Wells_Fargo___Compan. This prediction currently runs until 05.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Integra LifeSciences Holdings Corp | 15.094% | 15.094% |
| iShares Core DAX® | 1.662% | 4.835% |
| iShares Nasdaq 100 | 0.667% | 0.000% |
| iShares Nikkei 225® | -2.139% | -4.786% |
| iShares S&P 500 | 0.564% | 0.775% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Integra LifeSciences Holdings Corp diskutieren
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $49.00 price target on the stock, up previously from $40.00.
Ratings data for IART provided by MarketBeat